ArticleJournal of clinical microbiology2013
Molecular characterization of Achromobacter isolates from cystic fibrosis and non-cystic fibrosis patients in Madrid, Spain.
Article in Journal of clinical microbiology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed.
- Cefiderocol susceptibility of Achromobacter spp.: study of an accurately identified collection of 230 strains.Annals of clinical microbiology and antimicrobials · 2024Article
- Article
- Inhaled Bacteriophage Therapy for Multi-Drug ResistantThe Yale journal of biology and medicine · 2022Article
- Distribution ofJournal of clinical microbiology · 2022Article
- Characterization of theFrontiers in cellular and infection microbiology · 2022Article
- Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry for Rapid Detection of Isolates Belonging to the Epidemic Clones Achromobacter xylosoxidans ST137 and Achromobacter ruhlandii DES from Cystic Fibrosis Patients.Journal of clinical microbiology · 2021Article
- Adaptive Interactions ofPathogens (Basel, Switzerland) · 2021Article
- Genomic characterization ofMicrobial genomics · 2021Article
- Article
- Longitudinal Surveillance and Combination Antimicrobial Susceptibility Testing of Multidrug-ResistantAntimicrobial agents and chemotherapy · 2020Article
- AcGI1, a novel genomic island carrying antibiotic resistance integron In687 in multidrug resistant Achromobacter xylosoxidans in a teaching hospital in Thailand.FEMS microbiology letters · 2020Article
- Chronic Airway Colonization by Achromobacter xylosoxidans in Cystic Fibrosis Patients Is Not Sustained by Their Domestic Environment.Applied and environmental microbiology · 2018Article
- Prevalence and Outcomes of Achromobacter Species Infections in Adults with Cystic Fibrosis: a North American Cohort Study.Journal of clinical microbiology · 2017Article
- Achromobacter xylosoxidans is the predominant Achromobacter species isolated from diverse non-respiratory samples.Epidemiology and infection · 2016Article
- Epidemic Achromobacter xylosoxidans strain among Belgian cystic fibrosis patients and review of literature.BMC microbiology · 2016Review
- Distribution of innate efflux-mediated aminoglycoside resistance among different Achromobacter species.New microbes and new infections · 2016Article
- Clinical impact of Achromobacter xylosoxidans colonization/infection in patients with cystic fibrosis.Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologica · 2016Article
- Genotypic and phenotypic applications for the differentiation and species-level identification of achromobacter for clinical diagnoses.PloS one · 2014Article
- Detection of Achromobacter xylosoxidans in hospital, domestic, and outdoor environmental samples and comparison with human clinical isolates.Applied and environmental microbiology · 2013Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Multilocus sequence typing and nrdA sequence analysis identified 6 different species or genogroups and 13 sequence types (STs) among 15 Achromobacter isolates from cystic fibrosis (CF) patients and 7 species or genogroups and 11 STs among 11 isolates from non-CF patients. Achromobacter xylosoxidans was the most frequently isolated species among CF patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.